Medtronic’s Guardian Connect continuous glucose monitoring system earned FDA approval March 12. Here are four things to know. 1. The Guardian Connect system uses predictive analytics and artificial ...
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the ...
Medtronic has developed a Bluetooth-enabled continuous glucose monitoring system for patients with diabetes, that will connect to an iOS app, Medtronic Global Program Marketing Manager Samantha Katz ...
Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery systems ...
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...
DUBLIN, Aug. 31, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a strategic partnership with BioIntelliSense, a continuous ...
Nearly two years after submitting its MiniMed 780G insulin delivery system to the FDA for clearance, Medtronic is still awaiting the agency’s nod—though not for a lack of evidence to back the ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic began the U.S. rollout on Tuesday of its latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results